Hippocratic AI Raises $141M to Revolutionize Patient Care with AI Agents

Hippocratic AI Secures $141 Million in Series B Funding

Hippocratic AI, a company developing artificial intelligence solutions for patient-facing applications excluding diagnostics, has successfully raised $141 million in a Series B funding round. This substantial investment values the company at $1.64 billion.

Kleiner Perkins spearheaded the funding initiative, as was announced on Thursday. This latest round follows closely on previous funding successes for the startup.

Recent Funding History

Just nine months prior, Hippocratic AI secured $53 million in funding from General Catalyst and Andreessen Horowitz.

Furthermore, an additional $17 million was raised from Nvidia five months ago. Remarkably, the company is less than two years old.

Focus on Addressing Healthcare Shortages

Unlike many generative AI companies in the healthcare sector that concentrate on streamlining administrative processes, Hippocratic AI is tackling the critical shortage of healthcare professionals.

The company achieves this by developing AI agents capable of handling straightforward tasks. These include pre-operative protocols, remote monitoring of patients, and preparation for medical appointments.

Expanding Market Reach

Throughout 2024, Hippocratic AI has established contracts with 23 different health systems and insurance providers.

The newly acquired capital will be strategically utilized to broaden the product’s availability to additional markets and to facilitate international expansion.